An interactive web application to identify early Parkinsonian non-tremor-dominant subtypes
- PMID: 38175296
- DOI: 10.1007/s00415-023-12156-5
An interactive web application to identify early Parkinsonian non-tremor-dominant subtypes
Abstract
Background: Parkinson's disease (PD) patients with tremor-dominant (TD) and non-tremor-dominant (NTD) subtypes exhibit heterogeneity. Rapid identification of different motor subtypes may help to develop personalized treatment plans.
Methods: The data were acquired from the Parkinson's Disease Progression Marker Initiative (PPMI). Following the identification of predictors utilizing recursive feature elimination (RFE), seven classical machine learning (ML) models, including logistic regression, support vector machine, decision tree, random forest, extreme gradient boosting, etc., were trained to predict patients' motor subtypes, evaluating the performance of models through the area under the receiver operating characteristic curve (AUC) and validating by the follow-up data.
Results: The feature subset engendered by RFE encompassed 20 features, comprising some clinical assessments and cerebrospinal fluid α-synuclein (CSF α-syn). ML models fitted in the RFE subset performed better in the test and validation sets. The best performing model was support vector machines with the polynomial kernel (P-SVM), achieving an AUC of 0.898. Five-fold repeated cross-validation showed the P-SVM model with CSF α-syn performed better than the model without CSF α-syn (P = 0.034). The Shapley additive explanation plot (SHAP) illustrated that how the levels of each feature affect the predicted probability as NTD subtypes.
Conclusion: An interactive web application was developed based on the P-SVM model constructed from feature subset by RFE. It can identify the current motor subtypes of PD patients, making it easier to understand the status of patients and develop personalized treatment plans.
Keywords: Alpha-synuclein; Biomarker; Machine learning; Motor subtypes; Parkinson’s disease.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.
Similar articles
-
Use of machine learning method on automatic classification of motor subtype of Parkinson's disease based on multilevel indices of rs-fMRI.Parkinsonism Relat Disord. 2021 Sep;90:65-72. doi: 10.1016/j.parkreldis.2021.08.003. Epub 2021 Aug 11. Parkinsonism Relat Disord. 2021. PMID: 34399160
-
Predictive model and risk analysis for peripheral vascular disease in type 2 diabetes mellitus patients using machine learning and shapley additive explanation.Front Endocrinol (Lausanne). 2024 Feb 28;15:1320335. doi: 10.3389/fendo.2024.1320335. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38481447 Free PMC article.
-
Cerebrospinal fluid alpha-synuclein, amyloid beta, total tau, and phosphorylated tau in tremor-dominant Parkinson's disease.Acta Neurol Belg. 2023 Aug;123(4):1429-1437. doi: 10.1007/s13760-023-02251-9. Epub 2023 Mar 31. Acta Neurol Belg. 2023. PMID: 37000407
-
Machine Learning to Predict the Response to Lenvatinib Combined with Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma.Cancers (Basel). 2023 Jan 19;15(3):625. doi: 10.3390/cancers15030625. Cancers (Basel). 2023. PMID: 36765583 Free PMC article.
-
Nonmotor features of Parkinson's disease subtypes.Mov Disord. 2016 Aug;31(8):1095-102. doi: 10.1002/mds.26510. Epub 2016 Feb 10. Mov Disord. 2016. PMID: 26861861 Review.
Cited by
-
Decoding pulsatile patterns of cerebrospinal fluid dynamics through enhancing interpretability in machine learning.Sci Rep. 2024 Aug 1;14(1):17854. doi: 10.1038/s41598-024-67928-4. Sci Rep. 2024. PMID: 39090141 Free PMC article.
-
Correlation between Parkinson's disease subtypes and plasma uric acid/neutrophil-to-lymphocyte ratio.Neurol Sci. 2025 Jun 26. doi: 10.1007/s10072-025-08301-9. Online ahead of print. Neurol Sci. 2025. PMID: 40569534
References
-
- Zuo LJ, Yu SY, Wang F et al (2016) Parkinson’s Disease with Fatigue: Clinical Characteristics and Potential Mechanisms Relevant to α-Synuclein Oligomer. J Clin Neurol 12(2):172–180. https://doi.org/10.3988/jcn.2016.12.2.172 - DOI - PubMed - PMC
-
- Jankovic J, McDermott M, Carter J et al (1990) Variable expression of Parkinson’s disease: A base-line analysis of the DAT ATOP cohort. Neurology 40:1529–1529. https://doi.org/10.1212/WNL.40.10.1529 - DOI - PubMed
-
- Greenland JC, Williams-Gray CH, Barker RA (2019) The clinical heterogeneity of Parkinson’s disease and its therapeutic implications. Eur J Neurosci 49:328–338. https://doi.org/10.1111/ejn.14094 - DOI - PubMed
-
- Schiess MC, Suescun J (2015) Clinical Determinants of Progression of Parkinson Disease: Predicting Prognosis by Subtype. JAMA Neurol 72:859. https://doi.org/10.1001/jamaneurol.2015.1067 - DOI - PubMed
-
- Nabizadeh F, Sodeifian F, Kargar A (2023) Cerebrospinal fluid alpha-synuclein, amyloid beta, total tau, and phosphorylated tau in tremor-dominant Parkinson’s disease. Acta Neurol Belg. https://doi.org/10.1007/s13760-023-02251-9 - DOI - PubMed
MeSH terms
Grants and funding
- No. 12101532/National Natural Science Foundation of China
- Nos. 12001470/National Natural Science Foundation of China
- BE2021630/Jiangsu Provincial Key Research and Development Program
- XWKYHT20220158/Medical Science and Technology Innovation Project of Xuzhou Health Commission
- JBGS202203/Leadership program through open competition in Xuzhou Medical University
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous